UNSPSC 85815524: Introduction of low-dose interleukin-2 into central artery, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of low-dose interleukin-2 into central artery, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E06303

UNSPSC 85815524 Introduction of low-dose interleukin-2 into central artery, percutaneous approach is a Commodity code that shows minimal alignment with recent state and local procurement activity. The nominal code describes a specific clinical intervention procedure, but the recent opportunities posted under this code cover virtual urgent care, medical services, occupational health, cancer screening, employee wellness platforms, EMS revenue billing, behavioral health services, and opioid use disorder treatment—none of which match the interleukin-2 procedure itself. State and local procurement systems appear to have applied this code incorrectly to a broad range of healthcare service and staffing solicitations unrelated to interventional cardiology or immunotherapy delivery.

The issuing bodies span diverse state and local jurisdictions: state health departments (Nevada, Texas, Colorado, New Jersey), counties (Inland Empire, DeKalb, San Mateo, Boulder, Cobb, Santa Clara, Jackson, Sedgwick, Ventura, Solano, Brevard), cities (Ocala, Atlanta, Phoenix, Chicago), municipalities (Los Alamos), school districts (Parkway), transit and governance entities (Events DC, Sourcewell cooperative), and regional health authorities (IEHP, Nevada Health Authority). Recent high-value opportunities include Nevada Health Authority's PACE program (December 10, 2026 response deadline, fixed monthly capitation ranging from $4,532 to $8,804 per participant), the City of Phoenix cancer screening services (February 2, 2026 deadline, $3.5 million maximum annual value, five-year contract), and the County of San Mateo employee wellness portal (May 22, 2026 deadline, exceeding $200,000 over three years). Geographic activity clusters in California (San Mateo, Inland Empire), Nevada, Colorado, Texas, Georgia, Kansas, and Florida, with additional scattered activity across Illinois, Oregon, Arizona, Missouri, and New York. The code's recent activity does not support targeted business development for interventional cardiology or immunotherapy services; the mismatch between nominal scope and actual posted opportunities suggests procurement classification error rather than genuine market demand under this code's clinical definition.